As of February 2022, subscribers can view and filter individual regulatory alerts per region. If you want to get our monthly compilations, visit our alerts round-up section.
27th January 2023
20th January 2023
16th January 2023
13th January 2023
9th December 2022
1st December 2022
Germany:Â The Federal Office of Consumer Protection and Food Safety (BVL) has updated the list of notified e-cigarette products, which now contains 293,204 products. Only products notified at least six months ago are listed.
28th November 2022
16th November 2022
Germany: Following a meeting last week when members of the Bundestag discussed a smoking cessation study financed by the Federal Joint Committee, the body responsible for determining what medical care is covered by statutory health insurance, one of the study team has told ECigIntelligence that e-cigarettes will be given to participants as a harm reduction product. The study has four stages: psychological counselling, nicotine replacement therapy, smoking cessation medication, and harm reduction products.
2nd November 2022
Germany: In answer to a parliamentary question by opposition MP Hans-Jürgen Thies, the federal government said it was currently examining further measures to prevent certain products from being disposed of in household waste and that disposable e-cigarettes are covered by the draft EU Ecodesign Directive. The government will advocate rules on the replaceability of batteries and e-liquids that would ensure disposable e-cigarettes could no longer be placed on the market.
2nd November 2022
Germany: The Federal Office of Consumer Protection and Food Safety (BVL) has updated the list of notified e-cigarette products, which now contains 288,962 products. Only products notified at least six months ago are listed.
5th October 2022
Germany: The Federal Joint Committee responsible for defining what drugs statutorily insured people are entitled to has told ECigIntelligence that it has not yet decided whether e-cigarettes will be included as a smoking cessation drug. Discussions on the question were due to take place this year.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.